☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
METEOR trial
Ipsen's Cabometyx Receives Health Canada's Approval for the Treatment of Advanced Renal Cell Carcinoma (RCC) in Adults
September 20, 2018
Load more...
Back to Home